Amgen prezzo dell'azione
AMGN
#74

321,03 €
  

0.03%

Amgen Info

Capitalizzazione di mercato
173,26B €

0.03%

Volume quotidiano
85,71K €
Tipo di asset
Stock
Dipendenti
28000
Fondata
Apr 8, 1980
Exchange principale
Nasdaq
Settore
Biological Products, (No Diagnostic Substances)
Numero CIK
0000318154

Dati azionari tokenizzati

Prezzo medio tokenizzato
325,54 €
Differenza di prezzo
+4,5 €(+1.40%)
Cap di mercato tokenizzata
2,92K €

0.61%

Vol tokenizzato (24h)
735,47K €

5.1%

Emittenti
Contratti
Esploratori
Convertitore da AMGN a USD
AMGN
EUR
Andamento del prezzo
Basso
318,79 €
Alto
325,27 €

Caricamento dati

Attendere prego, stiamo caricando i dati del grafico

Amgen Community

skeleton-white
 
 
 
 
 
 

About Amgen

What is Amgen?

Amgen is a leader in biotechnology-based human therapeutics. Flagship drugs include red blood cell boosters Epogen and Aranesp, immune system boosters Neupogen and Neulasta, and Enbrel and Otezla for inflammatory diseases. Amgen introduced its first cancer therapeutic, Vectibix, in 2006 and markets bone-strengthening drugs Prolia/Xgeva (approved 2010) and Evenity (2019). The acquisition of Onyx Pharmaceuticals bolstered the firm's therapeutic oncology portfolio with Kyprolis. Recent launches include Repatha (cholesterol-lowering), Aimovig (migraine), Lumakras (lung cancer), and Tezspire (asthma). The 2023 Horizon acquisition brought several rare-disease drugs, including thyroid eye disease drug Tepezza. Amgen also has a growing biosimilar portfolio.

Amgen Prezzo in tempo reale

The current price of Amgen in the market is 321,03 €, with a 24-hour trading volume of 85,71K €. The asset's market cap is 173,26B €, after moving 0.03% in the last day.

Tokenized Amgen is trading at 325,54 €, with a tokenized market cap of 2,92K € and a 24-hour trading volume of 735,47K €. The tokenized asset has moved 0.61% in the past 24 hours.